Results for tag: "Cysticercosis Drug"

Cysticercosis is a parasitic infection caused by the larvae of the pork tapeworm. It is a major public health problem in many parts of the world, particularly in developing countries. Treatment of cysticercosis is mainly based on the use of antiparasitic drugs, such as albendazole and praziquantel. These drugs are used to kill the larvae and reduce the risk of further infection. The cysticercosis drug market is a subset of the infectious diseases drug market. It is driven by the increasing prevalence of cysticercosis, as well as the need for effective treatments. The market is expected to grow in the coming years, as more people become aware of the disease and its associated risks. Some of the major companies in the cysticercosis drug market include Merck & Co., Inc., GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., and Johnson & Johnson. These companies are actively involved in the development and marketing of drugs for the treatment of cysticercosis. Show Less Read more